American International Group, Inc. Pliant Therapeutics, Inc. Transaction History

American International Group, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$14.14 - $19.59 $3,421 - $4,740	-242 Reduced 0.85%	28,165 $419,000
Q4 2023 Feb 13, 2024	BUY	$12.85 - $19.15 $2,685 - $4,002	209 Added 0.74%	28,407 $514,000
Q3 2023 Nov 13, 2023	BUY	$14.58 - $20.15 $14,623 - $20,210	1,003 Added 3.69%	28,198 $488,000
Q2 2023 Aug 04, 2023	BUY	$18.12 - $30.56 $492,773 - $831,079	27,195 New	27,195 $492,000
Q2 2022 Aug 12, 2022	SELL	$4.11 - $8.75 $49,089 - $104,510	-11,944 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.01 - $14.1 $5,895 - $11,858	-841 Reduced 6.58%	11,944 $84,000
Q4 2021 Feb 11, 2022	SELL	$12.27 - $18.26 $4,699 - $6,993	-383 Reduced 2.91%	12,785 $173,000
Q3 2021 Nov 12, 2021	SELL	$16.48 - $28.98 $5,158 - $9,070	-313 Reduced 2.32%	13,168 $222,000
Q2 2021 Aug 13, 2021	SELL	$28.05 - $37.69 $14,529 - $19,523	-518 Reduced 3.7%	13,481 $393,000
Q1 2021 May 07, 2021	BUY	$24.52 - $40.23 $194,762 - $319,546	7,943 Added 131.16%	13,999 $551,000
Q4 2020 Feb 12, 2021	SELL	$19.89 - $32.99 $3,440 - $5,707	-173 Reduced 2.78%	6,056 $138,000
Q3 2020 Nov 04, 2020	BUY	$21.54 - $29.53 $134,172 - $183,942	6,229 New	6,229 $141,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.